Clinical trial
CPI-613 in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer
NCT01931787
Study timeline
Study start (actual)2013-10-01Date precision: month
Registry last updated2018-07-03
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Recurrent Small Cell Lung Cancerunresolved
Interventions
Sponsors & collaborators
Wake Forest University Health Scienceslead sponsor
National Cancer Institute (NCI)collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01931787 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.